Ethyl 3-tert-butyl-1,2,4-oxadiazole-5-carboxylate, 95.0%, 250mg

6-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95.0%, 250mg

m-Xylylene Diisocyanate>98.0%(GC)25g

Dodecanamide, N-[3',6'-bis(?-D-galactopyranosyloxy)-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl]-, 95%, 1mg

2-Fluoro-6-picoline-5-boronic acid, 95.0%, 250mg

2-(5-Bromopyridin-3-yl)propan-2-ol, 95.0%, 250mg

2-(5-Nitropyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline, 97.0%, 10g

4-chloro-N-(2,2,2-trifluoroethyl)aniline, 97%, 10g

(2-Cyano-4-fluorophenyl)boronic acid, 95.0%, 5g

Pinacol, 98.0%, 25g

Long working distance plan Fluarex 20x/0.45 infinity corrected IOS objective, corrected for 1 mm petri dish thickness

4-bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile, 95.0%, 500mg

Ethyl 4-amino-6-chloro-5-nitronicotinate, 95+%, 100mg